Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Saved in:
| Title: | Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. |
|---|---|
| Authors: | Sharman JP; a Willamette Valley Cancer Institute and Research Center , US Oncology Research , Eugene , OR , USA., Forero-Torres A; b University of Alabama School of Medicine , Birmingham , AL , USA., Costa LJ; c Division of Hematology/Oncology , Medical University of South Carolina , Charleston , SC , USA., Flinn IW; d Sarah Cannon Research Institute , Nashville , TN , USA., Inhorn L; e Blue Ridge Cancer Care , Roanoke , VA , USA., Kelly K; f USC Norris Comprehensive Cancer Center , Los Angeles , CA , USA., Bessudo A; g California Cancer Associates for Research and Excellence , San Diego , CA , USA., Fayad LE; h Department of Lymphoma and Myeloma , M.D. Anderson Cancer Center, University of Texas , Houston , TX , USA., Kaminski MS; i Division of Hematology/Oncology , University of Michigan Comprehensive Cancer Center, Ann Arbor , MI , USA., Evens AM; j Rutgers Cancer Institute of New Jersey , New Brunswick , NJ , USA., Flowers CR; k Winship Cancer Institute , Atlanta , GA , USA., Sahin D; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Mundt KE; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Sandmann T; m Genentech Inc. , South San Francisco , CA , USA., Fingerle-Rowson G; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Vignal C; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Mobasher M; m Genentech Inc. , South San Francisco , CA , USA., Zelenetz AD; n Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center , New York , NY , USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2019 Apr; Vol. 60 (4), pp. 894-903. Date of Electronic Publication: 2018 Oct 02. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30277102 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sharman+JP%22">Sharman JP</searchLink>; a Willamette Valley Cancer Institute and Research Center , US Oncology Research , Eugene , OR , USA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; b University of Alabama School of Medicine , Birmingham , AL , USA.<br /><searchLink fieldCode="AU" term="%22Costa+LJ%22">Costa LJ</searchLink>; c Division of Hematology/Oncology , Medical University of South Carolina , Charleston , SC , USA.<br /><searchLink fieldCode="AU" term="%22Flinn+IW%22">Flinn IW</searchLink>; d Sarah Cannon Research Institute , Nashville , TN , USA.<br /><searchLink fieldCode="AU" term="%22Inhorn+L%22">Inhorn L</searchLink>; e Blue Ridge Cancer Care , Roanoke , VA , USA.<br /><searchLink fieldCode="AU" term="%22Kelly+K%22">Kelly K</searchLink>; f USC Norris Comprehensive Cancer Center , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Bessudo+A%22">Bessudo A</searchLink>; g California Cancer Associates for Research and Excellence , San Diego , CA , USA.<br /><searchLink fieldCode="AU" term="%22Fayad+LE%22">Fayad LE</searchLink>; h Department of Lymphoma and Myeloma , M.D. Anderson Cancer Center, University of Texas , Houston , TX , USA.<br /><searchLink fieldCode="AU" term="%22Kaminski+MS%22">Kaminski MS</searchLink>; i Division of Hematology/Oncology , University of Michigan Comprehensive Cancer Center, Ann Arbor , MI , USA.<br /><searchLink fieldCode="AU" term="%22Evens+AM%22">Evens AM</searchLink>; j Rutgers Cancer Institute of New Jersey , New Brunswick , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Flowers+CR%22">Flowers CR</searchLink>; k Winship Cancer Institute , Atlanta , GA , USA.<br /><searchLink fieldCode="AU" term="%22Sahin+D%22">Sahin D</searchLink>; l F. Hoffmann-La Roche Ltd , Basel , Switzerland.<br /><searchLink fieldCode="AU" term="%22Mundt+KE%22">Mundt KE</searchLink>; l F. Hoffmann-La Roche Ltd , Basel , Switzerland.<br /><searchLink fieldCode="AU" term="%22Sandmann+T%22">Sandmann T</searchLink>; m Genentech Inc. , South San Francisco , CA , USA.<br /><searchLink fieldCode="AU" term="%22Fingerle-Rowson+G%22">Fingerle-Rowson G</searchLink>; l F. Hoffmann-La Roche Ltd , Basel , Switzerland.<br /><searchLink fieldCode="AU" term="%22Vignal+C%22">Vignal C</searchLink>; l F. Hoffmann-La Roche Ltd , Basel , Switzerland.<br /><searchLink fieldCode="AU" term="%22Mobasher+M%22">Mobasher M</searchLink>; m Genentech Inc. , South San Francisco , CA , USA.<br /><searchLink fieldCode="AU" term="%22Zelenetz+AD%22">Zelenetz AD</searchLink>; n Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center , New York , NY , USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2019 Apr; Vol. 60 (4), pp. 894-903. <i>Date of Electronic Publication: </i>2018 Oct 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30277102 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2018.1515940 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 894 Titles: – TitleFull: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sharman JP – PersonEntity: Name: NameFull: Forero-Torres A – PersonEntity: Name: NameFull: Costa LJ – PersonEntity: Name: NameFull: Flinn IW – PersonEntity: Name: NameFull: Inhorn L – PersonEntity: Name: NameFull: Kelly K – PersonEntity: Name: NameFull: Bessudo A – PersonEntity: Name: NameFull: Fayad LE – PersonEntity: Name: NameFull: Kaminski MS – PersonEntity: Name: NameFull: Evens AM – PersonEntity: Name: NameFull: Flowers CR – PersonEntity: Name: NameFull: Sahin D – PersonEntity: Name: NameFull: Mundt KE – PersonEntity: Name: NameFull: Sandmann T – PersonEntity: Name: NameFull: Fingerle-Rowson G – PersonEntity: Name: NameFull: Vignal C – PersonEntity: Name: NameFull: Mobasher M – PersonEntity: Name: NameFull: Zelenetz AD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2019 Apr Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 60 – Type: issue Value: 4 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
